Trulieve Earns Spot on TIME’s America’s Best Companies 2026 List

TALLAHASSEE – Trulieve Cannabis Corp. received recognition from TIME magazine as one of America’s Best Companies for 2026. The Florida-based medical Cannabis operator is one of only two Cannabis companies to appear on the list, drawn from a field of more than 7,200 eligible candidates.

The list, developed in partnership with Statista, evaluated thousands of U.S. companies on Employee Satisfaction, Revenue Growth, and Sustainability Transparency (ESG). Public and private firms that report relevant data qualified for consideration. Trulieve joined a select group, noted as one of the top performers in its category and ranked as the most sustainable Cannabis company.

Employee sentiment draws from approximately 217,000 verified survey responses collected over three years. Financial performance is assessed using multi-year data covering revenue growth, profitability, asset performance, and return on assets, with a minimum $100 million in 2025 revenue required for eligibility. The sustainability component uses Statista’s ESG database, covering environmental impact, social responsibility, and governance disclosures.

“Being named to TIME’s list of America’s Best Companies is a tremendous honor and a direct reflection of the durability of our business,” said CEO Kim Rivers. “To be one of only two cannabis companies recognized speaks to the passion and dedication of our team as we continue our mission to expand access to cannabis.”

This recognition comes at a pivotal time for Trulieve. In June, the company became the first U.S. Cannabis operator to list on the New York Stock Exchange, following a corporate restructuring that deconsolidated its adult-use operations and concentrated its footprint on state-licensed medical Cannabis businesses. The company emphasized its focus on operational efficiency, patient care, and environmental practices in cultivation and retail.

The underlying numbers hold up against the ranking’s criteria. For fiscal year 2025, Trulieve posted revenue of $1.2 billion with a 60% gross margin and a record adjusted EBITDA of $427 million – a 36% margin on revenue, supported by record cash flow from operations of $273 million. In the first quarter of 2026, the company reported $286.8 million in revenue, a 59% gross margin, and $100 million in adjusted EBITDA, with $353 million in cash on hand at quarter-end. Trulieve currently operates across 10 states, with medical dispensaries backed by 3.5 million square feet of production capacity.

For an industry that has rarely received favorable framing in mainstream institutional rankings, TIME’s inclusion of Trulieve [along with Aurora Cannabis Inc. named to TIME Canada’s Best Companies 2026 list] reflects something worth noting. The financial and operational discipline the sector has built over the past decade is now being measured against the same benchmarks applied to the broader U.S. corporate market.